ArticleDiabetology & metabolic syndrome2025
Enhanced risk of thrombosis in aged insulin-treated diabetic rats exposed to non-severe recurrent hypoglycemia.
Article in Diabetology & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundAntidiabetic treatment is linked with an increased risk of hypoglycemia. Several clinical studies have demonstrated that hypoglycemia exposure elevates the risk of cardiovascular diseases in diabetic patients. Our previous research has shown that non-severe recurrent hypoglycemia (RH) exposure increases the risk of thrombosis in young insulin-treated diabetic (ITD) rats. Given that a substantial subset of diabetes patients who experience cardiovascular complications are elderly and the effect of non-severe RH on thrombosis risk in aged subjects remains unknown, we tested the hypothesis that prior RH exposure enhances thrombosis in aged ITD rats.
methodsAged, insulin-treated streptozotocin-diabetic Wistar rats of both sexes were randomly assigned to either the recurrent hyperinsulinemic euglycemia control or the recurrent hyperinsulinemic hypoglycemia group. The risk of thrombosis was quantified using an in vivo model.
resultsRH increases the risk of thrombosis in male ITD rats 7 days after exposure. A twice-weekly hypoglycemia exposure for 6 weeks also elevated the risk of thrombosis in male rats. Similar exposures to RH also increased the risk of thrombosis in aged female rats.
conclusionsExposure to non-severe RH increases the risk of thrombosis in aged ITD rats of both sexes. Nonetheless, it remains uncertain whether aging influences the characteristics of thrombosis observed in RH-exposed young ITD rats as well as its clinical consequences, highlighting the need for further research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.